A clinical trial of FK 506 as primary and rescue immunosuppression in cardiac transplantation.
Armitage
J M
JM
University of Pittsburgh School of Medicine, Department of Surgery, Pennsylvania.
Kormos
R L
RL
Griffith
B P
BP
Hardesty
R L
RL
Fricker
F J
FJ
Stuart
R S
RS
Marrone
G C
GC
Todo
S
S
Fung
J
J
Starzl
T E
TE
D000328:Adult; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D003922:Diabetes Mellitus, Type 1 / Q000150:complications; D005260:Female; D006084:Graft Rejection; D006321:Heart / Q000502:physiology; D016027:Heart Transplantation / Q000379:methods*; D006801:Humans; D006973:Hypertension / Q000150:complications; D007165:Immunosuppression Therapy / Q000379:methods*; D007166:Immunosuppressive Agents; D007223:Infant; D007668:Kidney / Q000502:physiology; D008297:Male; D008875:Middle Aged; D009894:Opportunistic Infections / Q000150:complications; D011446:Prospective Studies; D016019:Survival Analysis; D016559:Tacrolimus
D000900:Anti-Bacterial Agents; D007166:Immunosuppressive Agents; D016559:Tacrolimus